Christine Marie Mellon net worth and biography

Christine Mellon Biography and Net Worth

Christine Mellon joined Omnicell in February 2021. As Chief People Officer she is responsible for leading HR functions, employee environments, and internal communications, including talent management, employee culture and engagement, diversity and inclusion, global rewards, business partnering, and real estate. Ms. Mellon has over 25 years of human resources, organizational, and cultural transformation leadership as well as sales and operations leadership experience. Prior to joining Omnicell she was Chief Human Resources Officer (CHRO) with CSG, where she transformed HR into a valued strategic asset and led culture change efforts. Before that she served as Vice President, Human Capital Management with Oracle where she consulted with North American CHRO clients, providing human capital strategic support, thought leadership and HR technology guidance. Ms. Mellon has also served in HR leadership roles for Echostar and Cigna, among others. Ms. Mellon holds a BA in Psychology from Villanova University.

What is Christine Marie Mellon's net worth?: The estimated net worth of Christine Marie Mellon is at least $390,792.52 as of June 9th, 2023. Ms. Mellon owns 14,876 shares of Omnicell stock worth more than $390,793 as of April 17th. This net worth estimate does not reflect any other investments that Ms. Mellon may own. Learn More about Christine Marie Mellon's net worth.
How do I contact Christine Marie Mellon?: The corporate mailing address for Ms. Mellon and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on Christine Marie Mellon's contact information.
Has Christine Marie Mellon been buying or selling shares of Omnicell?: Christine Marie Mellon has not been actively trading shares of Omnicell during the past quarter. Most recently, Christine Marie Mellon sold 7,951 shares of the business's stock in a transaction on Friday, June 9th. The shares were sold at an average price of $73.14, for a transaction totalling $581,536.14. Following the completion of the sale, the executive vice president now directly owns 14,876 shares of the company's stock, valued at $1,088,030.64. Learn More on Christine Marie Mellon's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, Omnicell insiders bought shares 1 times. They purchased a total of 4,000 shares worth more than $295,040.00. During the last year, insiders at the sold shares 1 times. They sold a total of 7,951 shares worth more than $581,536.14. The most recent insider tranaction occured on June, 9th when EVP Christine Marie Mellon sold 7,951 shares worth more than $581,536.14. Insiders at Omnicell own 2.6% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 6/9/2023.

Christine Marie Mellon Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/9/2023	Sell	7,951	$73.14	$581,536.14	14,876
5/4/2021	Buy	43	$137.64	$5,918.52	14,510

Christine Marie Mellon Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $26.27

$26.14

$26.93

50 Day Range

MA: $27.76

$26.15

$29.24

2 Week Range

Now: $26.27

$25.69

$77.14

Volume

412,368 shs

Average Volume

550,040 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.76

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report